This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Healthcare Realty Trust (HR) Receives a Hold from Jefferies
In a report released today, from Jefferies maintained a Hold rating on Healthcare Realty Trust, with a price target of $18.00.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Currently, the analyst consensus on Healthcare Realty Trust is a Moderate Buy with an average price target of $19.50.
Based on Healthcare Realty Trust’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $297.77 million and a GAAP net loss of $57.74 million. In comparison, last year the company earned a revenue of $315.42 million and had a GAAP net loss of $93.02 million
Read More on HR:
Disclaimer & DisclosureReport an Issue
- Healthcare Realty Trust price target raised to $19 from $18 at Wells Fargo
- Starboard takes new stake in Bill Holdings, exits Pfizer position
- Healthcare Realty Trust price target raised to $19 from $17 at Citi
- Healthcare Realty Trust’s Positive Earnings Call Highlights Growth
- Cautious Optimism: Hold Rating Maintained for Healthcare Realty Trust Amid Strategic Progress and Modest Financial Guidance
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
